Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.

The journal of allergy and clinical immunology. In practice - 1 Jan 2000

Ledford Dennis K, Wenzel Sally E, Lockey Richard F

Abstract excerpt

Aspirin-exacerbated respiratory disease (AERD) is an asthma phenotype with a prevalence that ranges from 2% to 25% of the asthma population. The 2% prevalence applies to patients with mild and 25% to severe, persistent asthma. COX-1-inhibiting nonsteroidal anti-inflammatory drugs, including aspirin, aggravate the preexisting upper and lower respiratory disease, sometimes in a life-threatening manner. The upper...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Aspirin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Comorbidity

Share to Cytokines

Share to Desensitization, Immunologic

Share to Immunoglobulin E

Share to Inflammation Mediators

Source

Identifiers

PMID: 25439353
DOI: 10.1016/j.jaip.2014.09.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.PMID 25439353Read ↗

Update on recent advances in the management of aspirin exacerbated respiratory disease.Semantic proximity Read ↗

Aspirin-exacerbated respiratory disease: an update.Semantic proximity Read ↗

Upper airways in aspirin-exacerbated respiratory disease.Semantic proximity Read ↗

Clinical Characteristics of Aspirin-Exacerbated Respiratory Disease.Semantic proximity Read ↗

Aspirin exacerbated respiratory disease (AERD): molecular and cellular diagnostic & prognostic approaches.Semantic proximity Read ↗

Physiopathology and genetics in aspirin-exacerbated respiratory disease.Semantic proximity Read ↗

Factors driving the aspirin exacerbated respiratory disease phenotype.Semantic proximity Read ↗

Pathogenesis of Aspirin-Induced Reactions in Aspirin-Exacerbated Respiratory Disease.Semantic proximity Read ↗

Efficacy of Biologics in Aspirin Exacerbated Respiratory Disease: A Narrative ReviewSemantic proximity Read ↗

Association of serum periostin with aspirin-exacerbated respiratory disease.Semantic proximity Read ↗

Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses. EAACI task force on eicosanoids consensus report in times of COVID-19Semantic proximity Read ↗

Increased expression of serine palmitoyl transferase and ORMDL3 polymorphism are associated with eosinophilic inflammation and airflow limitation in aspirin-exacerbated respiratory disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.